As the coronavirus pandemic spreads across the world and the pressure on health system and economies mounts, Pfizer and BioNTech have agreed to jointly develop a vaccine to prevent the infe
Two of the largest ever biotech IPOs have gone ahead this week, although both BioNTech and Vir Biotechnology were valued at the low end of their expected ranges.
Two of the largest-ever biotech initial public offerings (IPOs) are scheduled to go ahead in the coming week, after a flurry of smaller stock market launches last week.
Pfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of more effective influenza vaccines, joining other pharma giants in a promising mRNA-
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
